Please refer the enclosed file.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Evexia Lifecare Limited announced its Q2 FY26 unaudited results. Standalone revenue from operations fell to Rs 2,502.82 lakhs from Rs 2,670.91 lakhs in Q2 FY25, a decline of about 6%. Standalone net profit dropped to Rs 31.52 lakhs from Rs 69.41 lakhs, down roughly 55%. On a consolidated basis, Q2 net profit came in at Rs 37.19 lakhs versus Rs 93.80 lakhs a year ago. For the half year, consolidated revenue rose modestly to Rs 4,825.38 lakhs from Rs 4,701.03 lakhs, but net profit slipped to Rs 100.67 lakhs from Rs 160.10 lakhs. The auditor M.A. Shah & Co. issued a clean limited review report with no qualifications.
The quarter shows weaker top-line and sharply lower profits, which may weigh on sentiment. The company appears to have undertaken a major acquisition or large investment funded by borrowings, as standalone goodwill jumped from Rs 4,614.89 lakhs to Rs 71,380.85 lakhs and consolidated investing cash flows were heavily negative, financed by fresh long-term borrowings. Investors should watch how the new business performs in coming quarters.